B

BioMed Realty

Owns and manages life-science real estate.

Construction Accounting Intern - Construction Accounting

Fall 2026Posted on 7/30/2026
$25 - $30/hr
Internship
Bachelor's
San Diego, CA, USA
In PersonOnsite in San Diego, California; in-office schedule Monday-Thursday within 8AM-5PM.

About the job

Requirements
  • Pursuing a degree with a major or minor in Accounting
  • Interested in real estate, construction, or project-based accounting
  • Detail-oriented with strong analytical and organizational skills
  • Able to manage multiple priorities and meet deadlines
  • Available to work up to 20 hours per week during the academic year
Responsibilities
  • Assist in preparing and posting journal entries related to construction accounting activities
  • Support the review and processing of construction invoices, budgets, and contracts
  • Perform monthly balance sheet reconciliations and account analysis
  • Contribute to month-end close activities, including reporting and documentation
  • Collaborate with accounting team members across experience levels
  • Research and evaluate emerging A.I. tools for accounting related functions. Collaborate with cross‑functional team members to identify opportunities for A.I. usage and adoption.
Desired Qualifications
  • Research and evaluate emerging A.I. tools for accounting related functions
  • Collaborate with cross-functional team members to identify opportunities for A.I. usage and adoption

About the company

BioMed Realty is a real estate investment trust that acquires, develops, owns, and manages laboratory and office space for the life science industry, with properties in the United States and United Kingdom. It earns income by signing long-term leases with high-quality tenants such as pharmaceutical and biotechnology companies, research institutions, and government agencies, and provides ongoing property and asset management. The company differentiates itself by being one of the largest private owners and operators of life science real estate, offering specialized facilities in major innovation hubs and a stable, high-grade tenant base. Its goal is to deliver steady, long-term rental revenue while growing a premier portfolio that supports biotech and pharmaceutical ecosystems.

Company Size

201-500

Company Stage

N/A

Total Funding

$598.6M

Headquarters

San Diego, California

Founded

2004

Get referred to BioMed Realty

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Biogen’s 585 Broadway project and TransMedics’ headquarters lease lock in long-duration cash flow.
  • Babraham Research Campus fully leased its newest building in February 2026, validating UK demand.
  • Gateway of Pacific won a 2026 BOMA TOBY award, strengthening tenant confidence and pricing power.

What critics are saying

  • In July 2026, BioMed surrendered 1000 Washington Street and 321 Harrison Avenue to lenders.
  • Boston concentration remains dangerous; one-third of BioMed’s portfolio sits in the soft South End/Cambridge market.
  • If lease-up stalls again, 2027 refinancing pressure hits development-heavy campuses and blunts growth.

What makes BioMed Realty unique

  • 17.3 million square feet spans Boston, Bay Area, San Diego, Seattle, Cambridge, and U.K.
  • BioMed secured a 16-year, 498,000-square-foot TransMedics lease at Assembly Innovation Park in January 2026.
  • BioMed’s Blackstone-backed capital base supports large, mission-critical, build-to-suit lab campuses.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Paid Family Leave Benefits

401(k) Retirement Plan

Tuition Reimbursement

Flexible Spending Accounts

Commuter Benefits

Lifestyle Spending Account

Pet Insurance

ID Theft Insurance

Legal Insurance

Employee Assistance Program

100% Employer-Paid Life & AD&D Insurance

Short and Long Term Disability

Company News

AnaptysBio
Apr 13th, 2026
AnaptysBio Secures $40 Million Series D Financing | AnaptysBio, Inc.

Enables Advancement of First-In-Class Anti-Inflammatory Antibody Programs Through Key Clinical Studies   SAN DIEGO, California — AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology, today announced the completion of an

INACTIVE